Real-World Experience with Long-term Lecanemab Treatment: A Retrospective Chart Review in Early Alzheimer’s Disease (P12-3.012)

To provide real-world experience on the treatment of individuals with early Alzheimer’s disease with lecanemab.

Authors

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000210905
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-World Experience with Long-term Lecanemab Treatment: A Retrospective Chart Review in Early Alzheimer’s Disease (P12-3.012)

Edward L. Yellin, Hans Lutz, Angela Scott, David Weisman et al.
Neurology
Computational Drug Discovery Methods
article

Real-World Experience with Long-term Lecanemab Treatment: A Retrospective Chart Review in Early Alzheimer’s Disease (P12-3.012)

Edward L. Yellin, Hans Lutz, Angela Scott, David Weisman, M. Kodsi, M. Mosley, Saanvi Nimma
article en

Abstract

To provide real-world experience on the treatment of individuals with early Alzheimer’s disease with lecanemab.

NeurologyVol. 104(7_Supplement_1)
Openalex Percentile: Top 92%
Computational Drug Discovery Methods
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Real-World Experience with Long-term Lecanemab Treatment: A Retrospective Chart Review in Early Alzheimer’s Disease (P12-3.012) — Edward L. Yellin, Hans Lutz, et al. · Neurology (2025) | TGRS Research Map | TGRS